- Home
- NCNA vs MNDR Comparison
NCNA vs MNDR Comparison
Compare NCNA & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- MNDR
- Stock Information
- Founded
- NCNA 1997
- MNDR 2016
- Country
- NCNA United Kingdom
- MNDR Singapore
- Employees
- NCNA N/A
- MNDR N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- MNDR
- Sector
- NCNA Health Care
- MNDR
- Exchange
- NCNA Nasdaq
- MNDR Nasdaq
- Market Cap
- NCNA 6.6M
- MNDR 6.8M
- IPO Year
- NCNA 2017
- MNDR 2024
- Fundamental
- Price
- NCNA $3.86
- MNDR $0.78
- Analyst Decision
- NCNA
- MNDR
- Analyst Count
- NCNA 0
- MNDR 0
- Target Price
- NCNA N/A
- MNDR N/A
- AVG Volume (30 Days)
- NCNA 338.4K
- MNDR 701.5K
- Earning Date
- NCNA 08-20-2025
- MNDR 10-28-2025
- Dividend Yield
- NCNA N/A
- MNDR N/A
- EPS Growth
- NCNA N/A
- MNDR N/A
- EPS
- NCNA N/A
- MNDR N/A
- Revenue
- NCNA N/A
- MNDR $11,600,567.00
- Revenue This Year
- NCNA N/A
- MNDR $188,831.77
- Revenue Next Year
- NCNA N/A
- MNDR $76.44
- P/E Ratio
- NCNA N/A
- MNDR N/A
- Revenue Growth
- NCNA N/A
- MNDR 0.61
- 52 Week Low
- NCNA $2.78
- MNDR $0.73
- 52 Week High
- NCNA $1,650.00
- MNDR $8.00
- Technical
- Relative Strength Index (RSI)
- NCNA 41.45
- MNDR 35.84
- Support Level
- NCNA $2.82
- MNDR $0.74
- Resistance Level
- NCNA $3.60
- MNDR $0.93
- Average True Range (ATR)
- NCNA 0.24
- MNDR 0.07
- MACD
- NCNA 0.43
- MNDR -0.02
- Stochastic Oscillator
- NCNA 74.48
- MNDR 13.44
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.